Showing results (731-740 of 2,755) with videos related to

Sort By:
Pageof 276
Pharmacogenomics|August 13, 2015
Translating DPYD genotype into DPD phenotype: using the DPYD gene activity scoreLinda M Henricks, Carin A T C Lunenburg, Didier Meulendijks, et al.
Pharmacogenomics|November 12, 2015
Stevens-Johnson syndrome and toxic epidermal necrolysis: an update on pharmacogenetics studies in drug-induced severe skin reactionSara Rufini, Cinzia Ciccacci, Cristina Politi, et al.
Pharmacogenomics|November 12, 2015
TLR7 Gln11Leu single nucleotide polymorphism and response to treatment with imiquimod in patients with basal cell carcinoma: a pilot studyStefano Piaserico, Anna Michelotto, Anna C Frigo, et al.
Pharmacogenomics|November 12, 2015
Cost-effectiveness analysis of genotyping for HLA-B*5801 and an enhanced safety program in gout patients starting allopurinol in SingaporeDi Dong, Wei-Chuen Tan-Koi, Gim Gee Teng, et al.
Pharmacogenomics|November 12, 2015
PTEN and PI3K/AKT in non-small-cell lung cancerCristina Pérez-Ramírez, Marisa Cañadas-Garre, Miguel Ángel Molina, et al.
Pharmacogenomics|November 12, 2015
The future of pharmacogenetics in the treatment of heart failureMohamed Subhan Anwar, Muhammad Zaid Iskandar, Helen M Parry, et al.
Pharmacogenomics|November 12, 2015
Uncovering drug-responsive regulatory elementsMarcelo R Luizon, Nadav Ahituv
Pharmacogenomics|November 12, 2015
Prevalence of pain-related single nucleotide polymorphisms in patients of African origin with sickle cell diseaseEllie H Jhun, Yingwei Yao, Ying He, et al.
Pharmacogenomics|September 25, 2013
Effect of NR3C2 genetic polymorphisms on the blood pressure response to enalapril treatmentJian-Quan Luo, Lu-Yan Wang, Fa-Zhong He, et al.
Pharmacogenomics|March 3, 2012
Prediction of warfarin dose: why, when and how?Niclas Eriksson, Mia Wadelius
Pageof 276